Review: taking Evista and Cymbalta together


Summary

Drug interactions are reported among people who take Evista and Cymbalta together. This review analyzes the effectiveness and drug interactions between Evista and Cymbalta. It is created by eHealthMe based on reports of 169 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Evista and Cymbalta >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Evista

Evista has active ingredients of raloxifene. It is often used in osteoporosis. (latest outcomes from Evista 18,114 users)

Cymbalta

Cymbalta has active ingredients of duloxetine. It is often used in depression. (latest outcomes from Cymbalta 48,473 users)

On Jul, 19, 2016

169 people who take Evista, Cymbalta are studied.


Number of reports submitted per year:

Evista and Cymbalta drug interactions.

Drug effectiveness over time:

Evista:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 4 people)
  • 5 - 10 years: 0.0% - (0 of 3 people)
  • 10+ years: 100.0% - (1 of 1 people)
  • not specified: 0.0% - (0 of 0 people)
Cymbalta:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 2 people)
  • 1 - 2 years: 33.0% - (1 of 3 people)
  • 2 - 5 years: 75.0% - (3 of 4 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Evista:
  • female: 22.0% - (2 of 9 people)
  • male: 0.0% - (0 of 0 people)
Cymbalta:
  • female: 40.0% - (4 of 10 people)
  • male: 0.0% - (0 of 0 people)

Drug effectiveness by age:

Evista:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 100.0% - (1 of 1 people)
  • 50-59: 25.0% - (1 of 4 people)
  • 60+: 0.0% - (0 of 4 people)
Cymbalta:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 80.0% - (4 of 5 people)
  • 60+: 0.0% - (0 of 4 people)

Most common drug interactions over time *:

< 1 month:
  • nausea
  • anaemia
  • blood sodium decreased
  • colon cancer
  • duodenal ulcer
  • facial palsy
  • gastric ulcer
  • headache
  • hypotension
  • melaena
1 - 6 months:
  • hyperhidrosis
  • blood sodium decreased
  • hypersensitivity
  • paraesthesia
  • dizziness
  • feeling abnormal
  • headache
  • nausea
  • abdominal pain lower
  • agitation
6 - 12 months:
  • anger
  • confusional state
  • hyperhidrosis
  • nausea
  • tardive dyskinesia
  • tinnitus
  • vertigo
  • weight gain poor
1 - 2 years:
  • activities of daily living impaired
  • blindness
  • drug effect decreased
  • eye pain
  • feeling abnormal
  • headache
  • impaired driving ability
  • lip blister
  • loss of employment
  • photopsia
2 - 5 years:
  • anaemia
  • duodenal ulcer
  • endometrial hyperplasia
  • gastric ulcer
  • hypotension
  • melaena
  • pelvic discomfort
  • tardive dyskinesia
  • anger
  • arthralgia
5 - 10 years:
  • deep vein thrombosis
  • hospitalisation
  • oedema peripheral
  • pitting oedema
  • pulmonary embolism
  • weight increased
10+ years:
  • back disorder
  • back pain
  • bone density decreased
  • depression
  • gait disturbance
  • hypophagia
  • migraine
  • mobility decreased
  • muscle spasms
  • nausea
not specified:
  • depression
  • anxiety
  • headache
  • neuralgia
  • vomiting
  • contusion
  • hiatus hernia
  • vertigo
  • aphthous stomatitis
  • arthropathy

Most common drug interactions by gender *:

female:
  • headache
  • depression
  • anxiety
  • vomiting
  • nausea
  • neuralgia
  • pain
  • contusion
  • fatigue
  • hiatus hernia

Most common drug interactions by age *:

40-49:
  • vomiting
  • abdominal discomfort
  • abdominal pain upper
  • abdominal rigidity
  • asthenia
  • cholecystitis chronic
  • cholelithiasis
  • dizziness
  • hyperhidrosis
  • infection
50-59:
  • fatigue
  • headache
  • pain
  • paraesthesia
  • gastritis erosive
  • haemorrhoids
  • myelofibrosis
  • therapeutic response decreased
  • feeling abnormal
  • nausea
60+:
  • depression
  • anxiety
  • neuralgia
  • vertigo
  • aphthous stomatitis
  • arthropathy
  • cerebral cyst
  • headache
  • hiatus hernia
  • hypersensitivity

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Evista and Cymbalta?

Can you answer these questions?

More questions for: Evista, Cymbalta

You may be interested in these reviews

More reviews for: Evista, Cymbalta

On eHealthMe, Evista (raloxifene) is often used to treat osteoporosis. Cymbalta (duloxetine) is often used to treat depression. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.